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ASSESSING PATIENTS’ PREFERENCES FOR 
CONVENTIONAL AND HOMEOPATHIC 
TREATMENT FOR ASTHMA—A CONJOINT 
ANALYSIS STUDY
Ratcliffe J1, Van Haselen R2, Buxton MJ3, Hardy K2, Colehan J3, 
Partridge M4
1RTI Health Solutions, Manchester, UK; 2Royal London 
Homeopathic Hospital, London, UK; 3Brunel University, 
Uxbridge, UK; 4Whipps Cross Hospital, London, UK
OBJECTIVES: To investigate patient preferences for at-
tributes or characteristics associated with conventional
and homeopathic treatment for asthma and to investigate
the extent to which such preferences may differ between
patient sub-groups.
METHODS: The economic technique of conjoint analy-
sis (CA) was used to investigate patients’ strength of pref-
erence for several key attributes associated with services
for the treatment of asthma. A CA questionnaire was ad-
ministered to two samples of asthma outpatients of 18
years or older: 150 individuals receiving conventional
treatment at Whipps Cross Hospital, London, U.K.
(WC), and 150 individuals receiving homeopathic treat-
ment at the Royal London Homeopathic Hospital, Lon-
don, U.K. (RL).
RESULTS: An overall response rate of 47% was
achieved (n  142) of which 72 were from the conven-
tional treatment sample and 70 were from the homeo-
pathic treatment sample. Statistically significant attributes
in influencing preferences for both the WC and RL re-
spondents were the extent to which the doctor gives suffi-
cient time to listen to what you have to say, the extent to
which the treatment seems to relieve your symptoms and
the travel costs of attending an asthma consultation. In
addition, the extent to which the doctor treats you as a
whole person was also a statistically significant attribute
for the RL respondents.
CONCLUSIONS: This study has demonstrated that as-
pects associated with the delivery of asthma services are
important to patients in addition to treatment outcomes.
The homeopathic respondents expressed stronger prefer-
ences for the doctor to treat them as a whole person in
comparison to the patients receiving conventional treat-
ment. Conjoint analysis is a potentially useful tool for as-
sessing patient preferences for alternative modes of deliv-
ery of asthma services.
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POD1
ESTIMATING THE SEMI-FIXED COSTS OF A 
DAY-CASE EPISODE
Payne K, Elliott RA, Davies LM
University of Manchester, Manchester, UK
OBJECTIVE: A randomised controlled trial (RCT) was
designed to provide robust evidence about the relative
costs, patient benefits and acceptability of alternative an-
aesthetic agents in day surgery. Staff costs are the princi-
pal component of semi-fixed costs for health-care inter-
ventions. There is no published information on the
resource use associated with the staff involved during the
day-case episode. This study provided information on
day-case staff deployment and skill mix to calculate asso-
ciated resource use and semi-fixed costs.
METHODS: Non-participant observation was used to
measure staff resource use in the anaesthesia room and in
the operating theatre for a sample of recruited patients.
Face-to-face interviews were used to collect NHS staff’s sub-
jective estimates of resource use associated with the remain-
ing stages of the day-case episode. The NHS perspective
was taken. Published estimates (price year 2000) of NHS
staff salaries were used for unit costs.
RESULTS: One hundred ninety four day-case procedures
were observed in the anaesthetic room and operating the-
atre of the main study NHS Trust sites. Differences in
working practices in terms of skill mix were observed be-
tween the three hospital sites. There was also a difference
in the staff costs in the anaesthetic room and operating
theatre for adult and paediatric day-case surgery: anaes-
thetic room—£0.91 per minute per adult patient (95%
CI: £0.86 to 0.96, n  157) and £1.42 per minute per pae-
diatric patient (95% CI: £1.15 to 1.69, n  37, p  .05);
operating theatre—£2.15 per minute per adult patient
(95% CI: £1.99 to 2.31, n  157) and £2.07 per minute
per paediatric patient (95% CI £1.78 to 2.36, n  37).
CONCLUSION: This study detected differences in the
semi-fixed costs for adult and paediatric practice, and be-
tween sites. This suggests that differences in clinical prac-
tice between sites and patient groups must be accounted
for in economic evaluations, or erroneous conclusions
may be made.
POD2
USING CONTINGENT VALUATION IN A RCT 
FOR INDUCTION AND MAINTENANCE OF 
ANAESTHETIC AGENTS FOR 
DAY-CASE SURGERY
Elliott RA, Payne K, Davies LM
University of Manchester, Manchester, UK
OBJECTIVE: A randomised, controlled trial (RCT) quan-
tified the relative costs, patient benefits and acceptability
of alternative anaesthetic agents. The study explored the
patients’ perspective by obtaining their preferences and
contingent valuations of alternative anaesthetic agents for
day-case surgery.
METHODS: Telephone interviews, conducted at day
seven post-discharge, were used to explore the direction
and strength of preference (contingent valuation) for in-
duction and maintenance anaesthetics. Descriptive sce-
narios of the process and outcome of anaesthesia were
developed for both adult and paediatric patient groups
and handed to the patient or parent/guardian pre-dis-
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charge. Scenario 1 represented a valuation of inhaled ver-
sus intravenous induction and scenario 2 represented a
valuation of inhaled versus intravenous maintenance. An
open-ended question was directed to test understanding
of the exercise, and thus validity of the valuation given. A
thematic framework approach was used to analyze these
qualitative data. A second researcher checked the consis-
tency of the coding of the themes in a sub-sample of the
statements (inter-rater reliability).
RESULTS: 260 (81%) parents/guardians and 907 (85%)
adults recruited onto the RCT were telephoned around
day seven. 88% and 85% of parents/guardians’ and
adults’ responses were classed as valid, respectively. 69%
of adults preferred an injection for induction (mean CV:
£237, SD: £370) and 31% preferred a mask (mean CV:
£144, SD: £110, p  .05). 97% of adults selected the sce-
nario with a lower nausea and vomiting rate (mean CV:
£192, SD: £149). 57% of parent/guardians preferred a
mask for induction (mean CV: £255, SD: £259) and 43%
preferred an injection (mean CV: £221, SD: £177, ns).
99% of parents/guardians selected the scenario with a
lower nausea and vomiting rate (mean CV: £238, SD:
£194).
CONCLUSION: Contingent valuation was used success-
fully in this prospective study. Telephone interviewing
produced a high response rate and respondent under-
standing of the exercise was high.
POD3
THE PSYCHOMETRIC TESTING OF THE 
HUNGARIAN VERSION OF THE SYSTEMIC 
LUPUS ERYTHEMATOSUS DISEASE-SPECIFIC 
QUALITY OF LIFE QUESTIONNAIRE
Lovas K1, Gergely P1, Whalley D2, Meads D2, Kalo Z3
1Semmelweis University, Budapest, Hungary; 2Galen Research, 
Manchester, UK; 3Novartis Pharma AG, Basel, Switzerland
OBJECTIVE: Quality of life (QoL) is a key parameter in
describing the impact of Systemic Lupus Erythematosus
(SLE). The reliability and validity of the Hungarian ver-
sion of the SLEQoL were assessed with the intention of
using it in clinical and health economic trials and burden-
of-disease studies in Hungary.
METHODS: Data were collected through a postal survey
of patients with SLE. Participants completed the SLEQoL
and Nottingham Health Profile (NHP) on two occasions,
two weeks apart. Test-retest reliability was assessed by
correlating SLEQoL scores at the two time points. Inter-
nal consistency was assessed using Cronbach’s alpha co-
efficients. Evidence of construct validity was gained by
correlating SLEQoL scores with NHP section scores and
by testing whether the measure was able to distinguish
groups that differed according to self-perceived severity
of condition.
RESULTS: Fifty-three patients participated in the survey.
Mean age of the sample was 39.9 years (SD  12.2), 49
patients (92.5%) were female and mean disease duration
was 12.0 years (SD  8.2). Test-retest reliability for pa-
tients who had no change in their condition between ad-
ministrations was 0.94. Cronbach’s alpha coefficients
were 0.90 and 0.93 at times 1 and 2 respectively. The
highest correlation was observed with the emotional re-
actions section of NHP and the lowest with pain and
sleep disturbance. Patients who perceived the severity of
their condition to be moderate or quite severe obtained
higher SLEQoL scores (indicating poorer QoL) than
those who perceived their condition to be mild (p  .05).
CONCLUSION: The Hungarian SLEQoL was shown to
have good test-retest reliability, indicating that it pro-
duces little random measurement error. Evidence of va-
lidity was also good. The results provide preliminary evi-
dence that the instrument will be able to detect changes
in QoL occurring in routine clinical practice or in clinical
trials or studies.
POD4
COST-CONSEQUENCES OF ORTHOPAEDIC 
SURGERY IN HAEMOPHILIA PATIENTS
WITH INHIBITORS
Green C, De Cock E
MEDTAP International, London, UK
OBJECTIVES: To date, surgical interventions in people
with haemophilia and high-titre, high-responding inhibi-
tors have been largely restricted to life-threatening situa-
tions. This is to the detriment of patients who would ben-
efit from surgery in terms of reduced pain, a reduction in
the frequency of regular bleeding episodes and improved
quality of life. However, with the development of recom-
binant FVIIa (rFVIIa: Novo Nordisk Ltd) elective surgery
such as joint replacement can be carried out safely with
effective haemostasis. This study examines the cost-con-
sequences of surgical intervention in this patient group
over time, to establish an estimate of the net cost of sur-
gery.
METHODS: A modeling framework has been used to es-
timate costs associated with haemostasis (rFVIIa treat-
ment) in patients for nine surgical procedures, and to
consider the cost-consequences of the intervention over a
five-year time horizon. Key parameters in the model have
been obtained from available literature (i.e. assumption
of reduction in bleeding episodes) and expert opinion
from a leading Haemophilia Comprehensive Care Centre
(i.e., protocols for haemostasis required during ortho-
paedic surgery, physiotherapy and rehabilitation).
RESULTS: For a typical person with haemophilia with
inhibitors, weighing 75kg, experiencing one regular bleed
per month in the affected joint, the costs for haemostasis
associated with total hip replacement are an estimated
£322,911. However, the net cost, when considering the
reduced costs of treatment for regular minor bleeds over
the following 5 years, are £298,401 (cost-saving) when
treating first line with rFVIIa.
CONCLUSIONS: In addition to improved quality of life,
orthopaedic surgery in people with haemophilia and in-
hibitors may be cost-saving when the reduction in regular
